Fibroblast activation protein in liver fibrosis

被引：47
|
作者：
Lay, Angelina J. [1 ,4 ]
Zhang, Hui E. [1 ,4 ]
McCaughan, Geoffrey W. [2 ,3 ,4 ]
Gorrell, Mark D. [1 ,4 ]
机构：
[1] Centenary Inst, Liver Enzymes Metab & Inflammat Program, Sydney, NSW 2050, Australia
[2] Centenary Inst, Liver Injury & Canc Program, Sydney, NSW 2050, Australia
[3] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW 2050, Australia
[4] Univ Sydney, Fac Med & Hlth, Sydney, NSW 2006, Australia
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2019年 / 24卷
基金：
英国医学研究理事会;
关键词：
Fibroblast Activation Protein; Serine Protease; Hydrolase; Aminopeptidase; Dipeptidyl Peptidase; Prolyl Oligopeptidase; Fibrosis; Review; DIPEPTIDYL-PEPTIDASE-IV; EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA-ASSOCIATED FIBROBLASTS; REACTIVE STROMAL FIBROBLASTS; GROWTH-FACTOR; 21; EXTRACELLULAR-MATRIX; SUBSTRATE-SPECIFICITY; REMODELING INTERFACE; CRYSTAL-STRUCTURE; MMP-2; EXPRESSION;
D O I：
10.2741/4706
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Fibroblast activation protein (FAP) belongs to the dipeptidyl peptidase IV (DPP4; CD26) gene family. Other related genes in this family of enzyme include DPP4, 8 and 9. The FAP serine protease has the rare property of both dipeptidyl peptidase and endopeptidase activities capable of cleaving the post-proline bond at two or more residues from the N-terminus. FAP is involved in a variety of biological processes but its expression in healthy tissues is low. In contrast, FAP is significantly elevated in pathological conditions such as at sites of tissue remodelling and repair. Its differential pattern of expression in diseases supports the emerging concept for FAP as a potential disease biomarker as well as a useful therapeutic target for drug intervention. This review summarizes the current knowledge of FAP, particularly its diagnostic and pathological significance in liver fibrosis.
引用
收藏
页码：1 / 17
页数：17
相关论文
共 50 条
  • [1] Circulating Fibroblast Activation Protein activity as a liver fibrosis biomarker in NAFLD
    Zhang, H. E.
    Brewer, K.
    Jeffrey, G. P.
    Twigg, S. M.
    McCaughan, G. W.
    Williams, K. H.
    Adams, L. A.
    Gorrell, M. D.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S666 - S667
  • [2] The role of fibroblast activation protein (FAP) in cell adhesion, migration and liver fibrosis
    Wang, XM
    Yu, DM
    Schnapp, A
    Marguet, D
    Cordoba, S
    Rettig, W
    McCaughan, GW
    Gorrell, MD
    [J]. HEPATOLOGY, 2005, 42 (04) : 738A - 738A
  • [3] Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
    Yang, Ai-Ting
    Kim, Yong-Ook
    Yan, Xu-Zhen
    Abe, Hiroyuki
    Aslam, Misbah
    Park, Kyoung-Sook
    Zhao, Xin-Yan
    Jia, Ji-Dong
    Klein, Thomas
    You, Hong
    Schuppan, Detlef
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 15 (04): : 841 - 867
  • [4] Circulating fibroblast activation protein enzyme activity as a biomarker of liver fibrosis in NAFLD
    Hannah, N.
    Kemp, W.
    Crest, P.
    Roberts, S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 102 - 103
  • [5] Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
    Jaiwoo Lee
    Junho Byun
    Gayong Shim
    Yu-Kyoung Oh
    [J]. Nature Communications, 13
  • [6] Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
    Lee, Jaiwoo
    Byun, Junho
    Shim, Gayong
    Oh, Yu-Kyoung
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [7] Fibroblast activation protein and chronic liver disease
    Wang, Xin Maggie
    Yao, Tsun-Wen
    Nadvi, Naveed A.
    Osborne, Brenna
    McCaughan, Geoffrey W.
    Gorrell, Mark D.
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 3168 - 3180
  • [8] Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
    Pirasteh, Ali
    Periyasamy, Sarvesh
    Meudt, Jennifer Jean
    Liu, Yongjun
    Lee, Laura M.
    Schachtschneider, Kyle M.
    Schook, Lawrence B.
    Gaba, Ron C.
    Mao, Lu
    Said, Adnan
    McMillan, Alan Blair
    Laeseke, Paul F.
    Shanmuganayagam, Dhanansaya
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (12) : 1956 - 1961
  • [9] Radiolabeled fibroblast activation protein inhibitors in the evaluation of myocardial fibrosis
    Su, Xiangyu
    Zhao, Yiheng
    Zhou, Xiang
    [J]. CHINESE MEDICAL JOURNAL, 2023, 136 (19) : 2377 - 2379
  • [10] A Protective Role For Fibroblast Activation Protein (FAP) In Pulmonary Fibrosis
    Fan, M.
    Majumdar, R. S.
    Kinder, M.
    Razvi, M.
    Christofidou-Solomidou, M.
    Pure, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
12345